Dr. Gabriel Tinoco Suarez, MD – Columbus, OH

  • Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondr...  

    Luyuan Li, Ana C Paz, Breelyn A Wilky, Britt Johnson, Karina Galoian, Andrew Rosenberg, Guozhi Hu, Gabriel Tinoco, Olaf Bodamer, Jonathan C Trent, PloS one, 9/14/2015
  • The biology and management of cartilaginous tumors: a role for targeting isocitrate dehydrogenase.  

    Tinoco G, Wilky BA, Paz-Mejia A, Rosenberg A, Trent JC, Am Soc Clin Oncol Educ Book., 5/2015
  • You Might Also Like